在肺腺癌中,SFXN1介导的免疫细胞透和瘤发生:一个潜在的治疗点

Yanjun Li1, Wenke Yang2, Chaojun Liu3

  • 1Department of Anaesthesiology and Perioperative Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan 450003, China.

概括

西德罗素1 (SFXN1) 在肺腺癌 (LUAD) 中升高,与不良结果有关. 向SFXN1可能会抑制LUAD的生长,并改变瘤的免疫微环境.